[{"Assets_0_Q3_USD":451505000.0,"CommonStockSharesOutstanding_0_Q3_shares":27098042.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-53712000.0,"NetIncomeLoss_1_Q3_USD":-31033000.0,"NetIncomeLoss_3_Q3_USD":-77073000.0,"StockholdersEquity_0_Q3_USD":420892000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO, INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]